Acneiform Eruptions Possibly Triggered by Clarithromycin During Sirolimus Treatment
Authors:
Open Access
- 25 May 2024
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 16 (5) , e61084
Abstract
Acneiform eruption is the recognized dermatological side effect of sirolimus, an inhibitor of the mammalian target of rapamycin, although the pathophysiological mechanisms and dose dependency of this side effect remain unclear. This case report describes a case of a 40-year-old Japanese woman treated with systemic sirolimus who developed acneiform eruptions following the administration of clarithromycin. The acneiform eruption resolved after discontinuation of sirolimus and relapsed with the resumption. Since sirolimus and clarithromycin have a potential drug-drug interaction mediated by cytochrome P450 3A (CYP3A), this case suggests that the acneiform eruption developed in association with elevated blood levels of sirolimus. We conclude that clinicians should be aware of the possibility of developing acneiform eruption during sirolimus treatment, especially when administered with medications that inhibit CYP3A.Keywords
This publication has 11 references indexed in Scilit:
- Therapeutic Drug Monitoring of Blood Sirolimus and Tacrolimus Concentrations for Polypharmacy Management in a Lymphangioleiomyomatosis Patient Taking Two Cytochrome P450 3A InhibitorsThe Tohoku Journal of Experimental Medicine, 2023
- Epidermal Growth Factor Receptor Cell Proliferation Signaling PathwaysCancers, 2017
- Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variationPharmacology & Therapeutics, 2013
- Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trialThe Lancet, 2013
- mTOR inhibitor‐associated dermatologic and mucosal problemsClinical Transplantation, 2010
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009
- Acne in recipients of renal transplantation treated with sirolimus: Clinical, microbiologic, histologic, therapeutic, and pathogenic aspectsJournal of the American Academy of Dermatology, 2006
- Sirolimus-Induced Acneiform EruptionDermatology, 2005
- Sirolimus: its discovery, biological properties, and mechanism of actionTransplantation Proceedings, 2003
- Clarithromycin: Review of a New Macrolide Antibiotic with Improved Microbiologic Spectrum and Favorable Pharmacokinetic and Adverse Effect ProfilesAnnals of Pharmacotherapy, 1992